Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

PREDICTIVE VALUE OF CEREBROSPINAL-FLUID POLYAMINES IN MEDULLOBLASTOMA CANCER RESEARCH MARTON, L. J., Edwards, M. S., Levin, V. A., LUBICH, W. P., Wilson, C. B. 1979; 39 (3): 993-997

Abstract

Seventy-five cerebrospinal fluid polyamine determinations were evaluated in 16 patients with medulloblastoma. Parameters utilized in evaluating patient status for correlation with the polyamine concentrations were neurological examination, computerized tomography, radionuclide scan, myelography, and cerebrospinal fluid cytology. Fifteen of the 16 patients showed absolute correlation with the eventual clinical picture. One determination on one patient resulted in a false negative. No false positives have been observed to date.

View details for Web of Science ID A1979GL34100049

View details for PubMedID 427786